News | October 14, 2024
Indian drug regulator recommends Wockhardt's Miqnaf for treatment of CABP
Wockhardt's yet another novel antibiotic Miqnaf receives favourable recommendation from Subject Expert Committee of CDSCO
Wockhardt's yet another novel antibiotic Miqnaf receives favourable recommendation from Subject Expert Committee of CDSCO
We now rank 3rd in pharmaceutical production by volume and 14th by value
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
